ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.128,41
1,27%
Dow Jones
38.682,65
1,20%
Euro vs US Dollar
1,0769
0,36%
Bitcoin
61.913,98
4,72%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) News

PRFX PainReform Ltd

0,82505
-0,09495 (-10,32%)
Zuletzt aktualisiert: 21:39:56
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
PainReform Ltd PRFX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,09495 -10,32% 0,82505 21:39:56
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,93 0,81 0,966 0,92
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202420:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16.4.202414:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09.4.202415:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02.4.202414:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
07.3.202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.3.202422:34EDGAR2Form F-1 - Registration statement for certain foreign..
01.3.202414:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01.3.202414:00GLOBEPainReform Provides Year-End Business Update
29.2.202422:37EDGAR2Form 20-F - Annual and transition report of foreign private..
22.1.202414:30GLOBEPainReform to Present at the Microcap Conference in Atlantic..
22.1.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19.1.202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12.1.202422:15EDGAR2Form F-3 - Registration statement by foreign private issuers
03.1.202414:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.1.202414:30GLOBEPainReform Reports Successful Head-to-Head Comparison of..
27.12.202322:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27.12.202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.12.202300:00GLOBEPainReform Announces Exercise of Warrants for Approximately..
15.11.202322:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.11.202322:05GLOBEPainReform Provides Business Update for the Third Quarter of..
11.9.202314:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.9.202314:30GLOBEPainReform Announces Plans to Commence Second Part of Phase..
07.9.202316:00GLOBEPainReform Selected for Poster Presentation at the 13th..
05.9.202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05.9.202314:30GLOBEPainReform to Participate in the H.C. Wainwright 25th Annual..
25.8.202322:15EDGAR2Form F-1 - Registration statement for certain foreign..
10.8.202322:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10.8.202322:05GLOBEPainReform Provides Business Update for the Second Quarter..
19.7.202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19.7.202315:00GLOBEPainReform Regains Compliance with Nasdaq Continued Listing..
18.7.202317:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18.7.202317:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.7.202321:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14.7.202320:35GLOBEPainReform Announces Pricing of $1.5 Million Concurrent..
14.7.202318:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14.7.202318:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.7.202315:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.7.202315:05GLOBEPainReform Announces Pricing of $2.7 Million Concurrent..
29.6.202322:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.6.202314:30GLOBEPainReform to Present at the Maxim Group Virtual Healthcare..
07.6.202322:30GLOBEPainReform Provides Regulatory Update on Second Part of its..
18.5.202315:00GLOBEPainReform Announces Positive Pharmacokinetic (PK) Data in..
15.5.202322:45GLOBEPainReform Provides Business Update for the First Quarter of..

Kürzlich von Ihnen besucht

NASDAQ
PRFX
PainReform
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten